OSENCABTAGENE AUTOLEUCEL EXPRESSED BIVALENT ANTI-CD7 NANO-ANTIBODY SEQUENCE ENDOPLASMIC RETICULUM RETENTION SEQUENCE (CD7-BLOCKING GENE)
UNII 7PQ69TH9VF

Substance Identification & Data

This profile provides standardized clinical and technical data for Osencabtagene Autoleucel Expressed Bivalent Anti-cd7 Nano-antibody Sequence Endoplasmic Reticulum Retention Sequence (cd7-blocking Gene), uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7PQ69TH9VF.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
7PQ69TH9VF
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
OSENCABTAGENE AUTOLEUCEL EXPRESSED BIVALENT ANTI-CD7 NANO-ANTIBODY SEQUENCE ENDOPLASMIC RETICULUM RETENTION SEQUENCE (CD7-BLOCKING GENE)
Official standardized name for this substance within the FDA UNII nomenclature system.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Osencabtagene Autoleucel Expressed Bivalent Anti-cd7 Nano-antibody Sequence Endoplasmic Reticulum Retention Sequence (cd7-blocking Gene). Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

OSENCABTAGENE AUTOLEUCEL EXPRESSED BIVALENT ANTI-CD7 NANO-ANTIBODY SEQUENCE ENDOPLASMIC RETICULUM RETENTION SEQUENCE (CD7-BLOCKING GENE)

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record